Motus GI Holdings, Inc.
Motus GI Holdings, Inc.
Your view on MOTS
Overview
What the company does, where it operates, and who runs it.
About Motus GI Holdings, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ravit Ram
- Headquarters
- 1301 East Broward Boulevard, Fort Lauderdale, FL, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ravit Ram
- Headquarters
- 1301 East Broward Boulevard, Fort Lauderdale, FL, US
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures.
The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Motus GI Holdings, Inc., and the rating behind it. MOTS last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Motus GI Holdings, Inc.. Starting points for Motus GI Holdings, Inc.: EPS -$15.89, beta 3.75 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Motus GI Holdings, Inc.. Motus GI Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Motus GI Holdings, Inc.. Trailing twelve-month EPS for Motus GI Holdings, Inc. stands at -$15.89. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Motus GI Holdings, Inc.. Motus GI Holdings, Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Motus GI Holdings, Inc. valued side by side against its closest peers. Motus GI Holdings, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Motus GI Holdings, Inc., and how their positions are changing. At a $639 market value, institutional positions materially move Motus GI Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Motus GI Holdings, Inc. executives and directors. Shares of Motus GI Holdings, Inc. have traded between $0.0000 and $0.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Motus GI Holdings, Inc.. Motus GI Holdings, Inc. is a $639 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Motus GI Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Motus GI Holdings, Inc.. Coverage tracks Motus GI Holdings, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.